NDC 37662-1066

Lithium Bromatum

Lithium Bromatum

Lithium Bromatum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Lithium Bromide.

Product ID37662-1066_e4d4dc18-3e34-9d4c-e053-2995a90a15b4
NDC37662-1066
Product TypeHuman Otc Drug
Proprietary NameLithium Bromatum
Generic NameLithium Bromatum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-07-28
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameLITHIUM BROMIDE
Active Ingredient Strength500 [hp_C]/1
Pharm ClassesMood Stabilizer [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-1066-1

200 PELLET in 1 VIAL, GLASS (37662-1066-1)
Marketing Start Date2022-07-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lithium Bromatum" or generic name "Lithium Bromatum"

NDCBrand NameGeneric Name
37662-1061Lithium BromatumLithium Bromatum
37662-1062Lithium BromatumLithium Bromatum
37662-1063Lithium BromatumLithium Bromatum
37662-1064Lithium BromatumLithium Bromatum
37662-1065Lithium BromatumLithium Bromatum
37662-1066Lithium BromatumLithium Bromatum
37662-1067Lithium BromatumLithium Bromatum
37662-1068Lithium BromatumLithium Bromatum
68428-974Lithium bromatumLITHIUM BROMIDE
71919-420Lithium bromatumLITHIUM BROMIDE
60986-1019LithiumLithium Bromatum

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.